Argus Upgrades Eli Lilly (LLY) to Buy

Argus upgraded Eli Lilly (NYSE: LLY) from Hold to Buy with a price target of $115.00.

For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.

Shares of Eli Lilly closed at $85.52 yesterday.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• BofA Securities Double Upgrades Comet Holding AG (COTN:SW) to Buy on NAND activity
• Mizuho Upgrades Five Below (FIVE) to Outperform, 'we believe the pendulum has swung too far on valuation'